Pfenex (PFNX) Tops Q4 EPS by 11c, Miss on Revenue

Pfenex (NYSE: PFNX) reported Q4 EPS of $0.23, $0.11 better than the analyst estimate of $0.12. Revenue for the quarter came in at $17.9 million versus the consensus estimate of $21.9 million.

For earnings history and earnings-related data on Pfenex (PFNX) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown